Indeed, ITGB1 is essential for cancer chemo-resistance and metastasis mediated by aberrant actin-bundling protein in breast cancer stem cells [52], and its signaling foster resistance to inhibitors of HER2 and PI3K in HER2+ breast cancer [53, 54]. Here, ERBB2 is linked to breast carcinoma.